We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
(+11%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$871K |
| 2 |
Broadcom
AVGO
|
+$691K |
| 3 |
Agilent Technologies
A
|
+$650K |
| 4 |
Telos
TLS
|
+$640K |
| 5 |
Pagaya Technologies
PGY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$730K |
| 2 |
Vertiv
VRT
|
+$639K |
| 3 |
Zevra Therapeutics
ZVRA
|
+$635K |
| 4 |
BOW
Bowhead Specialty Holdings
BOW
|
+$608K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$581K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Industrials | 15.13% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
TAL Education Group
TAL
$5.79B
| $137K | 0.07% |
12,535
-10,244
| -45% | -$116K |
|
627
Telus
TU
$16.7B
| $135K | 0.07% |
+10,228
| New | +$144K |
|
628
Algoma Steel
ASTL
$463M
| $135K | 0.07% |
+32,839
| New | +$131K |
|
629
DMC Global
BOOM
$112M
| $134K | 0.07% |
20,078
-409
| -2% | -$2.82K |
|
630
Embecta
EMBC
$213M
| $133K | 0.07% |
+11,235
| New | +$148K |
|
631
El Pollo Loco
LOCO
$497M
| $133K | 0.07% |
+12,757
| New | +$132K |
|
632
Petco
WOOF
$811M
| $132K | 0.07% |
47,082
-4,761
| -9% | -$15.4K |
|
633
VTEX
VTEX
$745M
| $131K | 0.07% |
34,928
-52,050
| -60% | -$214K |
|
634
eHealth
EHTH
$43.2M
| $131K | 0.07% |
+28,497
| New | +$126K |
|
635
SFL Corp
SFL
$1.61B
| $131K | 0.07% |
+16,738
| New | +$129K |
|
|
ZENA
636
ZenaTech Inc
ZENA
$116M
| $129K | 0.07% |
+40,188
| New | +$167K |
|
|
EWCZ
637
DELISTED
European Wax Center
EWCZ
| $125K | 0.06% |
34,788
+4,332
| +14% | +$16.2K |
|
|
ACRE
638
Ares Commercial Real Estate
ACRE
$256M
| $125K | 0.06% |
+26,066
| New | +$127K |
|
639
TETRA Technologies
TTI
$1.07B
| $123K | 0.06% |
13,151
-829
| -6% | -$6.4K |
|
640
Definitive Healthcare
DH
$74.6M
| $120K | 0.06% |
41,769
+12,215
| +41% | +$33.9K |
|
|
NKLR
641
Terra Innovatum Global N.V.
NKLR
$577M
| $119K | 0.06% |
+25,852
| New | +$181K |
|
642
Endava
DAVA
$153M
| $116K | 0.06% |
+18,381
| New | +$141K |
|
643
Lumen
LUMN
$6.38B
| $116K | 0.06% |
+14,916
| New | +$123K |
|
644
Delcath Systems
DCTH
$399M
| $113K | 0.06% |
11,220
-3,815
| -25% | -$37.9K |
|
|
KC
645
Kingsoft Cloud Holdings
KC
$3.03B
| $112K | 0.06% |
+10,865
| New | +$133K |
|
|
RERE
646
ATRenew
RERE
$959M
| $112K | 0.06% |
+21,111
| New | +$94.6K |
|
647
Imperial Petroleum
IMPP
$212M
| $112K | 0.06% |
+30,876
| New | +$152K |
|
648
CryoPort
CYRX
$765M
| $109K | 0.06% |
11,362
-5,136
| -31% | -$48.5K |
|
649
Capitol Federal Financial
CFFN
$1.09B
| $108K | 0.05% |
15,860
-15,465
| -49% | -$101K |
|
650
A2Z Smart Technologies
AZ
$263M
| $107K | 0.05% |
+16,379
| New | +$105K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.
- PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
- PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
- PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
- PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
- PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
- PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
- PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.
Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.